Home

Angus C. Russell

CIK 1534002 · last filed 2026-07-02

Angus C. Russell is a corporate insider who has filed 68 SEC Form 4 insider transactions across 7 companies since 2013. The most recent filing, for LCTX, was dated Jul 2, 2026. Across all open-market trades the lifetime net is +$844.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $105.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$105.6K

Companies

7

Total Filings

68

Lifetime Open-Market Net

$844.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LCTX Director 87,500 $1.07 $93.6K -$14.0K 8 2026-07-02
GPCR Director — $47.89 — $0 3 2026-06-18
Revance Therapeutics, Inc. (RVNC) Delisted Director 0 $3.65 $0 $100.7K 14 2025-02-06
TXMD Director 5,792 $2.06 $11.9K $422.7K 15 2022-10-03
Keenova Therapeutics plc (MNK) Delisted Director 0 $0.34 $0 -$6.7K 13 2020-11-16
Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Director 67,500 — — $191.5K 5 2018-07-03
QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Director 5,114 — — $150.0K 3 2013-11-13

Recent Filings

68 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 LCTX Grant (A) — $0 EDGAR
2026-06-18 GPCR Grant (A) — $0 EDGAR
2025-07-02 LCTX Grant (A) — $0 EDGAR
2025-06-25 GPCR Grant (A) — $0 EDGAR
2025-02-06 Revance Therapeutics, Inc. (RVNC) Delisted Mixed −51,506 -$133.2K EDGAR
2024-08-28 GPCR Grant (A) — $0 EDGAR
2024-07-03 LCTX Grant (A) — $0 EDGAR
2024-05-03 Revance Therapeutics, Inc. (RVNC) Delisted Grant (A) +15,000 $0 EDGAR
2023-07-03 LCTX Grant (A) — $0 EDGAR
2023-05-05 Revance Therapeutics, Inc. (RVNC) Delisted Grant (A) +3,534 $0 EDGAR
Showing 1–10 of 68
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.